Fragile X syndrome (FraX) is the most common known cause of inherited mental impairment. FMR1 gene mutations, the cause of FraX, lead to reduced expression of FMR1 protein and an increased risk for a particular profile of cognitive, behavioral, and emotional dysfunction. The study of individuals with FraX provides a unique window of understanding into important disorders such as autism, social phobia, cognitive disability, and depression. This review highlights the typical phenotypic features of individuals with FraX, discussing the apparent strengths and weaknesses in intellectual functioning, as evidenced from longitudinal follow-up studies. It also discusses recent neuroanatomic findings that may pave the way for more focused disease-specific pharmacologic and behavioral interventions. This article describes the results of recent medication trials designed to target symptoms associated with FraX. It also describes some recent behavioral interventions that were conducted in our laboratory.
Fragile X syndrome: assessment and treatment implications. Publishing Authors By Initials
Fragile X syndrome: assessment and treatment implications. Journal Published:
PUBLICATION TYPE: Review
Journal: Child and adolescent psychiatric clinics of North
VOLUME: 16
Page Numbers: 663-75
Journal Abbreviation:
ISSN: 1056-4993
DAY: 3
MONTH: Jul
YEAR: 2007
Fragile X syndrome: assessment and treatment implications. Information
Number of References: 85
LANGUAGE: eng
NlmUniqueID: 9313451
Fragile X syndrome: assessment and treatment implications. Keywords Mesh Terms:
KEYWORDS: Mental Retardation
MESH TERMS: genetics
Chemical & Substance for Abstract: Fragile X syndrome: assessment and treatment implications. Information
Substance Name: Fragile X Mental Retardation Protein
Registry Number: 139135-51-6
Grant and Affiliation Information for Fragile X syndrome: assessment and treatment implications.
AFFILIATION: Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305-5975, USA.
Country: United States
AGENCY: United States NIMH
GRANT: MH64708
ACRONYM: MH
MEDLINETA: Child Adolesc Psychiatr Clin N
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Fragile X syndrome: assessment and treatment implications Related Publications